Launch week offerEnds in00h00m00s

annual Promonthly Pro

stefania cheli

PhD, professional technical collaborator

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Gianvincenzo Zuccotti

University of Milan

ITALY

View details

Carla Carnovale

University of Milan

ITALY

View details

spinello antinori

Full Professor of Infectious Diseases

University of Milan

ITALY

View details

Dario Cattaneo

Associate Professor of Pharmacology

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

stefania cheli

Research Interests

Make your next move.

Explore related searches

Articles (17)

Fever in a palliative care setting: Clinical insights and implications from a prospective observational cohort study

Real-World Patterns of Delayed Cutaneous Adverse Reactions to Antimicrobial Therapy in Children: A Case Series and FAERS Analysis Across Age Groups

Olmesartan-Induced Enteropathy: Case Reports and Insights From FDA Adverse Event Reporting System (FAERS)

Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series

NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort

NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study

Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]

Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study

One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report

ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients

Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?

Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: a 5-year single center experience.

Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?

Collaborators (4)

Gianvincenzo Zuccotti

Carla Carnovale

spinello antinori

Dario Cattaneo

Make your next move.